Early Phase 1 Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part in the study.
- You are between 5 and 70 years old.
- Your vitiligo affects 10% or less of your body's skin surface area.
Who may not be able to join:
- You are currently using or have previously used any treatments for vitiligo.
- You are pregnant or currently breastfeeding.
- Your vitiligo is considered unstable, meaning it is still actively spreading or changing (confirm with trial site).
- You are taking medications that suppress the immune system for another health condition.
- You have anaemia (low red blood cells), a weakened immune system, a bleeding or clotting disorder, or epilepsy, or you take blood-thinning or anti-clotting medications.
- You have a history of raised, thickened, or overgrown scar tissue (such as keloid or hypertrophic scars).
- You have had an allergic reaction to either of the medications being used in this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Re-pigmentation of vitiligo patches of patients treated with 5FU with micro-needling versus potent topical steroids at week 12 as assessed by decrease in VASI (Vitiligo Area Scoring Index) scores, ranging from score 0 to 100.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.